Qualitative development and content validity of the non-small cell lung cancer symptom assessment questionnaire(NSCLC-SAQ), A patient reported outcome instrument [ J ]. Clinical Therapeu- tics,2016,38 (4) :794- 810.McCarrier KP, Atkinson TM, Debusk KPA, Liepa AM, Scanlon M, Coons SJ. ...
The NSCLC-SAQ uses a 7-day recall period and verbal rating scales. It was developed in accordance with the US Food and Drug Administration's PRO Guidance and scientific best practices, and the resulting qualitative interview data provide evidence of content validity. The NSCLC-SAQ has been ...